CD155 overexpression is a hallmark observed in multiple malignancies, including lung adenocarcinoma,[56] colorectal cancer,[57] pancreatic cancer,[58] and high‐grade gliomas, such as GBM (Grade IV),[45, 59] and promotes tumor migration and invasion. This evidence concerns the gene PVR and pancreatic neoplasm.